RECRUITINGOBSERVATIONAL
Genome Analysis Across Populations in Inflammatory Bowel Disease
About This Trial
Objective: To use clinical, genetic and genome analysis to better understand and define the genetic and environmental factors that contribute to IBD within affected populations.
Who May Be Eligible (Plain English)
Who May Qualify:
- Subjects: diagnosed with Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis, IBD-undetermined)
- Available medical records to confirm IBD diagnosis (Crohn's disease, Ulcerative colitis, IBD undetermined (IBD-U))
- Healthy controls: no personal history of IBD, no family history of IBD, no history of unexplained chronic diarrhea/blood in stool/anemia/abdominal pain/weight loss
- Any age
Who Should NOT Join This Trial:
\- Subjects with other gastrointestinal conditions not meeting the above IBD or Healthy Control criteria
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Subjects: diagnosed with Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis, IBD-undetermined)
* Available medical records to confirm IBD diagnosis (Crohn's disease, Ulcerative colitis, IBD undetermined (IBD-U))
* Healthy controls: no personal history of IBD, no family history of IBD, no history of unexplained chronic diarrhea/blood in stool/anemia/abdominal pain/weight loss
* Any age
Exclusion Criteria:
\- Subjects with other gastrointestinal conditions not meeting the above IBD or Healthy Control criteria
Treatments Being Tested
GENETIC
Blood or saliva sample collection
Blood or saliva sample \& clinical data collection
Locations (1)
Sinai Health System
Toronto, Ontario, Canada